𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study

✍ Scribed by Thomas R. Fleming; Thomas D. Brown; S. William Ross; John S. Macdonald

Publisher
Springer US
Year
1995
Tongue
English
Weight
202 KB
Volume
13
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adjuvant therapy of osteosarcomaβ€”A Phase
Adjuvant therapy of osteosarcomaβ€”A Phase II trial : Southwest Oncology Group study 9139
✍ Mark M. Zalupski; Cathryn Rankin; James R. Ryan; David R. Lucas; Jeffrey Muler; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 101 KB

## Abstract ## BACKGROUND The objective of this study was to estimate the time to treatment failure and survival rate of the three‐drug combination of doxorubicin, cisplatin, and ifosfamide as primary and postoperative, adjunctive treatment for teenagers and adults with osteosarcoma (OS). ## METH

Phase II evaluation of mitoxantrone in a
Phase II evaluation of mitoxantrone in advanced pancreatic carcinoma: A Southwest Oncology Group study
✍ Sarah A. Taylor; Thomas Fleming; Daniel D. Hoff; Joseph D. McCracken; Ronald M. πŸ“‚ Article πŸ“… 1990 πŸ› Springer US 🌐 English βš– 242 KB

Patient with advanced adenocarcinoma of the pancreas and no prior chemotherapy were treated on a Phase II trial of mitoxantrone. Doses were adjusted for hepatic dysfunction as defined by bilirubin. Twenty-four patients with a bilirubin less than or equal to 1.5 mg% received mitoxantrone 12 mg/m2 i.v

An eastern cooperative oncology group ph
An eastern cooperative oncology group phase II trial of trimetrexate in the treatment of advanced urothelial carcinoma
✍ Robert S. Witte; Paul Elson; Janardan Khandakar; Donald L. Trump πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 359 KB πŸ‘ 2 views

## Background. Trimetrexate is an antifol that differs from methotrexate in ways that may be clinically important. Because methotrexate has activity in advanced bladder cancer, this trial was initiated.

Phase II trial of carboplatin and paclit
Phase II trial of carboplatin and paclitaxel in cisplatin-pretreated advanced transitional cell carcinoma : A Southwest Oncology Group study
✍ Ulka N. Vaishampayan; James R. Faulkner; Eric J. Small; Bruce G. Redman; Wayne L πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 86 KB

## Abstract ## BACKGROUND The purpose of the study was to assess the efficacy and toxicity of carboplatin and paclitaxel administered every 3 weeks in patients with advanced urothelial carcinoma, previously treated with cisplatin‐based therapy. ## METHODS Eligibility included metastatic or local